CJC-1295 + Ipamorelin: what the evidence actually shows
Peptides (GH secretagogues)
This is the most-marketed “anti-aging peptide stack” in commercial clinics, yet the combined PubMed record is tiny — roughly 33 indexed papers for CJC-1295 and 54 for ipamorelin, a few dozen human records between them, mostly pharmacology from the 2000s. They demonstrably raise growth-hormone and IGF-1 levels; nobody has shown that this improves aging outcomes, and chronically raising IGF-1 points the wrong way in most longevity biology.
PubMed footprint (2026-08-29): 33 indexed publications, 21 involving humans (search: "CJC-1295").
What they are
CJC-1295 is a long-acting analogue of growth-hormone-releasing hormone; ipamorelin is a selective ghrelin-receptor agonist. Both push the pituitary to release more growth hormone, which is why clinics pair them: one lengthens the signal, the other adds pulses.
What the research actually shows
Early pharmacology confirmed the hormone-raising mechanism in humans — elevated GH pulses and IGF-1 over days to weeks. Development largely stopped there, and no outcome trial in healthy aging adults has ever been published. Marketing claims about muscle, sleep, fat loss and “cellular repair” are extrapolated from GH physiology, not demonstrated with this stack.
Risks and open questions
Chronically elevated GH/IGF-1 raises glucose-regulation concerns and theoretical tumour-growth questions — notable because most longevity research associates lower, not higher, IGF-1 signalling with longer lifespan in model organisms. Water retention and carpal-tunnel-like symptoms are reported with GH elevation generally.
FAQ
Do CJC-1295 and ipamorelin raise growth hormone?
Yes — that mechanism is documented in early human pharmacology studies.
Is there evidence they slow aging?
No outcome trial exists. Longevity biology generally links lower, not higher, chronic IGF-1 signalling with longer lifespan in models.
Are they allowed in sport?
No — GH secretagogues are prohibited by WADA.
Sources & further reading
→ Evaluating a clinic that sells this? Build a provider question list
Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.